Skip to main content
. Author manuscript; available in PMC: 2009 Nov 15.
Published in final edited form as: Cancer Res. 2008 Nov 15;68(22):9338–9347. doi: 10.1158/0008-5472.CAN-08-0265

Figure 6. Illustration of PXR and OATP1A2 interplay in breast cancer.

Figure 6

The interplay of PXR activation and therefore modulation of OATP1A2 expression and function in breast cancer cells is illustrated. Induction of OATP1A2 is expected to result in increased cellular uptake of hydrophilic estrogen metabolites leading to the increased estrogenic effects. This interplay can be modulated by the specific PXR antagonist A-792611.